Try our corporate solution for free!
+1 (212) 419-5770
support@statista.com

Teva Pharmaceutical Industries' specialty medicines revenues breakdown 2016-2019

This statistic shows the specialty medicines revenues breakdown of pharmaceutical company Teva from 2016 to 2019, by product. Teva Pharmaceutical Industries is one of the largest generic drug manufacturers in the world. In 2019, top product Copaxone generated revenues of around 1.5 billion U.S. dollars.

Leading specialty medicines of Teva Pharmaceutical Industries by revenue from 2016 to 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until September 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2020

Region

Worldwide

Survey time period

2016 to 2019

Supplementary notes

* Revenue of Treanda/Bendeka is only for North America.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Teva"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.